from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3823c/mmpL8

LFCtreatmentdescriptionclass of inhibitor

-0.422

Amikacinug/mL Amikacintranslation

-1.088

Cap5-10ug/mL Capreomycintranslation

-1.479

Rox10-50 ug/mL Roxithromycintranslation

-0.131

SM2-5 ug/mL Streptomycintranslation

0.596

Tet5-10 ug/mL Tetracyclinetranslation

1.686

Rif0.2-5ug/mL Rifampicintranscription

-0.272

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.231

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.102

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.646

CPZ10-50 ug/mL Chlorpromazinerespiration

0.200

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.128

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.754

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.715

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.064

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.241

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.197

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.518

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.619

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.224

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.512

KCN5-20 ug/mL Potassium cyaniderespiration

-0.700

NaN30.2-2 mM Sodium aziderespiration

-0.571

Nigericin50 uM Nigericinrespiration

-0.015

TRC10-150 ug/mL Triclosanrespiration

-0.290

TRZ10-25 ug/mL Thioridazinerespiration

-2.089

Valinomycin0.5-10 uM Valinomycinrespiration

-1.508

ZnSO42 mM ZnSO4respiration

-1.040

menadione6-10 ug/mL Menadionerespiration

0.302

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.252

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.075

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.127

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.542

NRP_1Non-replicating persistence stage 1dosRassociated

0.495

Amp0.2mg/mL AmpicillincellWall

-0.224

Cephalexin20-100 ug/mL CephalexincellWall

-0.442

Cerulenin0.32-5 ug/mL CerulenincellWall

0.946

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.867

EMB10-20 ug/mL EthambutolcellWall

0.231

Eta12-40 ug/mL EthionamidecellWall

0.396

INH0.2-0.4 ug/mL IsoniazidcellWall

1.383

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.672

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.252

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.292

BZA0.12 mg/mL BenzamidearomaticAmides

-0.071

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.253

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.663

H2O24 mM hydrogen peroxideDNAdamaging

-0.297

Levo10 ug/mL LevofloxacinDNAdamaging

0.180

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.030

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.551

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.147

UVUV-irradiationDNAdamaging

-0.394

ARP41-4 ug/mL Antitubercular compound ARP4?

0.469

Antimycin12.5-50 ug/mL Antimycin A?

0.122

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.117

PA_110-50 ug/mL Antitubercular compound PA-1?

0.586

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.148

PA8240.2-2 ug/mL PA-824?

-1.731

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.266

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.488

Verapamil50 uM Verapamil?

-0.032

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.366

methoxatin10-20 ug/mL Methoxatin?